Anula Jayasuriya, Director at Lineage Cell Therapeutics, Inc. (LCTX), bought 10,000 shares at $1.09 ($11K) on 2023-12-29, disclosed to the SEC on 2024-01-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.